Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to Rituximab
Public ClinicalTrials.gov record NCT02792699. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind Study to Compare Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of ABP 798 With Rituximab in Subjects With Moderate to Severe Rheumatoid Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is designed to determine what effects the human body has on the investigational medicine, ABP 798, and what effects the body has on the investigational medicine after you have been given it, and if this is comparable to what is seen for the licensed medicine, rituximab, in patients with moderate or severe RA. This study will also assess if the investigational medicine is safe and effective in treating moderate or severe RA compared to the licensed medicine.
Study identification
- NCT ID
- NCT02792699
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 311 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 17, 2016 (Actual)
- Primary completion
- Oct 8, 2018 (Actual)
- Completion
- Oct 8, 2018 (Actual)
- Last update posted
- Oct 6, 2020
2016 – 2018
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tuscaloosa | Alabama | 35406 | — |
| Research Site | Los Angeles | California | 90095-1670 | — |
| Research Site | Thousand Oaks | California | 91360 | — |
| Research Site | Upland | California | 91786 | — |
| Research Site | Aventura | Florida | 33180 | — |
| Research Site | Edgewater | Florida | 32132 | — |
| Research Site | Hialeah | Florida | 33012 | — |
| Research Site | Orlando | Florida | 32810 | — |
| Research Site | Vero Beach | Florida | 32960 | — |
| Research Site | Idaho Falls | Idaho | 83404 | — |
| Research Site | Lexington | Kentucky | 40504 | — |
| Research Site | Lansing | Michigan | 48910 | — |
| Research Site | Flowood | Mississippi | 39232 | — |
| Research Site | Las Vegas | Nevada | 89128 | — |
| Research Site | Charlotte | North Carolina | 28210 | — |
| Research Site | Oklahoma City | Oklahoma | 73112 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | Orangeburg | South Carolina | 29118 | — |
| Research Site | Summerville | South Carolina | 29486 | — |
| Research Site | Memphis | Tennessee | 38119 | — |
| Research Site | Carrollton | Texas | 75007-1601 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | League City | Texas | 77573 | — |
| Research Site | Mesquite | Texas | 75150 | — |
| Research Site | Plano | Texas | 75024 | — |
| Research Site | Olympia | Washington | 98502 | — |
| Research Site | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02792699, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2020 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02792699 live on ClinicalTrials.gov.